In the world of biochemistry and laboratory research, few compounds have garnered as much interest among enthusiasts as th 19 Feb 2024 — SS-31, also known as Bendavia or elamipretide, is a mitochondria-targeting peptide that accumulates in mitochondria and scavenges reactive oxygen species. e es 31 peptide. Often referred to in scientific literature by its development codes, such as MTP-131 or Bendavia, this compound represents a fascinating frontier in the study of cellular components. As someone who follows advancements in laboratory research, I have spent significant time reviewing the data surrounding this unique, mitochondria-targeting peptide.
Understanding the es 31 peptide
At its core, SS-31, ALSO KNOWN as elamipretide, is a synthetic mitochondria-targeting tetrapeptide. When we look at the structural biology, it is a small peptide th Improving mitochondrial function with SS-31 reverses age at accumulates in mitochondria, specifically targeting the inner mitochondrial membrane. My interest in this subject began when I learned that mitochondria are the “engines” of the cell, and any research into their efficiency is inherently compelling.
In the lab, SS 31 (Elamipretide) is frequently studied for its role a Improving mitochondrial function with SS-31 reverses age s a mitochondria-targeting antioxidant. Unlike broad-spectrum antioxidants, its ability to localize within the organelle allows for a more nuanced approach to examining oxidative stress.
Key Observations and Research Context
When reviewing papers, it becomes clear that SS-31, a peptide that targets mitochondria, operates through a specific mechanism. It is a short peptide under investigation in the area of mitochondrial bioenergetics and function. Here are some of the focal points for those researching this compound:
* Mitochondrial Energetics: Researchers often highlight an energizing effect from its action on mitochondrial function. This is typically the primary by Y Zhu · 2022 · Cited by 73 — SS-31, a mitochondria-targeting antioxidant, has received significant research attention as it decreases mitochondrial reactive oxygen species production. metric observed in experimental models.
* Cellular Defense: It is widely documented that SS-31 is reported to protect against mitochondrial dysfunction by scavenging reactive oxygen species (ROS).
* Structural Specificity: As a synthetic mitochondria-targeting tetrapeptide, its sequence allows it to interact uniquely with cardiolipin, a phospholipid essential for mitochondrial health.
Insights into Experimental Applications
For those curious about the "how" and "why" behind the excitement, it is important to understan 19 Feb 2024 — SS-31, also known as Bendavia or elamipretide, is a mitochondria-targeting peptide that accumulates in mitochondria and scavenges reactive oxygen species. d that this is not a substance meant for human intake. Rather, it is a research tool. Many providers, such as RCpeptides, which supplies ultra-pure research peptides, emphasize that these materials are intended exclusively for *in-vitro* or laboratory research.
In various studies, the mitochondrial targeted peptide SS-31 has been evaluated for its potential in diverse areas:
1. Bioenergetics: Observing how the cell manages energy conversion when the peptide is present.
2. Neuroprotec Elamipretide: Uses, Side Effects, Dosage tion: There is ongoing inquiry into whether SS-31 has been proposed as a potential agent for neuroprotection, though this remains strictly within the realm of experimental models.
3. General Cellular Health: It is a small peptide being studied for its powerful impact on mitochondrial health, particularly in environments where oxidative stress is elevated.
Distinguishing Fact from Speculat Elamipretide is an investigational drug being developed to treat mitochondrial diseases, yet to be approved by the FDA, but has received orphan drug status. ion
It is vital to maintain clarity regarding the classification of this compound. While some sources might mention it in the context of Barth syndrome or as an investigational drug being developed to treat mitochondrial diseases, it is essential to distinguish between clinical drug development and the raw research peptides available to hobbyists and scientists.
When I look at the SS-31 (Elampretide) data, I am always reminded that scientific progress is incremental. Whether you are looking at a SS-31 peptide dosage chart or researching a specific SS-31 peptide protocol, remember that these are tools for controlled study.
Final Thoughts on Research Quality
If you are sourcing materials for your own laboratory research, purity is the most critical factor. Verified, third-party tested products ensure that your observations are based on the compound itself rather than contaminants. SS-31 is a peptide that shows significant promise in the literature, and as researchers, our goal should be to maintain the highest standards of integrity in our experimental setups.
B Can the SS-31 Peptide Stop Your Eyes From Aging? y focusing on the mitochondria-targeted peptide SS-31 in a controlled manner, we contribute to the broader understanding of how cellular energy systems can be supported and maintained through rigorous, evidence-based inquiry.